| abstract |
The present invention provides a deuterated compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula I are as defined in the specification. The compound of Formula I is useful for the treatment of cancer such as non-small cell lung cancer, ovarian cancer, renal cell carcinoma, hepatocellular carcinoma, and glioblastoma multiforme, and/or fibrosis, such as pulmonary fibrosis, including IPF. |